📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

KOPRANPharmaceuticals

Kopran Ltd — Financial Ratios & Key Metrics

₹108.04

-6.75%

P/E Ratio38.54xIndustry: 31.77x

ROE7.64%Return on equity

ROCE9.75%Return on capital

Debt/Equity0.31Low debt

💎

Valuation & Profitability

P/E Ratio

38.54x

Industry Average P/E

31.77x

Dividend Yield

2.13%

Market Cap

₹678.69 (Cr)

Sales Growth 5Y

11.86%

Profit Growth 5Y

12.38%

EPS Growth 5Y

9.95%

OPM 5Y Avg

13.33%

📉

Price Returns

1 Month

-14.97%

3 Months

-12.01%

6 Months

-26.65%

1 Year

-35.30%

52W Low

₹111

Current

₹108

52W High

₹214

-3% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹129

▼ Price below SMA 50 — Bearish

SMA 200

₹155

▼ Long-term downtrend

Volume Signal

200% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Kopran Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.